Huang J et al., having studied the complement components C3a, C5a, soluble C5b-9, C4d, C1q, MBL, and Bb in the plasma and urine of patients with FSGS, concluded that there was systemic complement activation in these patients. The gene discussed is C5; the disease is focal segmental glomerulosclerosis.